GreenLight Biosciences's net tangible assets is $22M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
GreenLight Biosciences (GRNA) currently reports a net tangible assets of $22M as of March 2023. That compares with $64M in the prior-year period — down 65.6% year over year. Use the charts on this page to explore GreenLight Biosciences's net tangible assets history and peer comparisons.
GreenLight Biosciences's net tangible assets decreased from $64M to $22M — a 65.6% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
GreenLight Biosciences reported $22M in net tangible assets as of March 2023. That compares with $64M in the prior-year period — down 65.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net tangible assets of $22M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GreenLight Biosciences, and consider following GRNA for alerts when major investors trade the stock.